Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. financial statements

Lyra Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 398KEODHD
Net income−USD 28.92MEODHD
Cash and equivalentsUSD 15.89MEODHD
Total debtUSD 30.26MEODHD

Lyra Therapeutics, Inc. financials on 6ix · Lyra Therapeutics, Inc. on 6ix